Recursion Pharmaceuticals Inc (RXRX)
Recursion Pharmaceuticals Market Cap: 2.239B for May 17, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 17, 2024 | 2.239B |
May 16, 2024 | 2.260B |
May 15, 2024 | 2.379B |
May 14, 2024 | 2.389B |
May 13, 2024 | 2.253B |
May 10, 2024 | 2.044B |
May 09, 2024 | 2.053B |
May 08, 2024 | 2.042B |
May 07, 2024 | 2.089B |
May 06, 2024 | 2.125B |
May 03, 2024 | 2.101B |
May 02, 2024 | 2.089B |
May 01, 2024 | 1.982B |
April 30, 2024 | 1.859B |
April 29, 2024 | 1.948B |
April 26, 2024 | 1.929B |
April 25, 2024 | 1.862B |
April 24, 2024 | 1.886B |
April 23, 2024 | 1.829B |
April 22, 2024 | 1.805B |
April 19, 2024 | 1.746B |
April 18, 2024 | 1.758B |
April 17, 2024 | 1.774B |
April 16, 2024 | 1.798B |
April 15, 2024 | 1.850B |
Date | Value |
---|---|
April 12, 2024 | 1.998B |
April 11, 2024 | 2.119B |
April 10, 2024 | 2.038B |
April 09, 2024 | 2.159B |
April 08, 2024 | 2.138B |
April 05, 2024 | 2.107B |
April 04, 2024 | 2.073B |
April 03, 2024 | 2.121B |
April 02, 2024 | 2.083B |
April 01, 2024 | 2.225B |
March 28, 2024 | 2.339B |
March 27, 2024 | 2.386B |
March 26, 2024 | 2.422B |
March 25, 2024 | 2.471B |
March 22, 2024 | 2.462B |
March 21, 2024 | 2.499B |
March 20, 2024 | 2.598B |
March 19, 2024 | 2.523B |
March 18, 2024 | 2.680B |
March 15, 2024 | 2.633B |
March 14, 2024 | 2.530B |
March 13, 2024 | 2.576B |
March 12, 2024 | 2.473B |
March 11, 2024 | 2.433B |
March 08, 2024 | 2.626B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
Eli Lilly and Co | 731.81B |
Absci Corp | 521.88M |
Palatin Technologies Inc | 32.27M |
Oragenics Inc | 10.44M |
Actinium Pharmaceuticals Inc | 291.88M |
Market Cap Related Metrics
PS Ratio | 45.50 |
PEG Ratio | -0.3344 |
Price to Book Value | 5.581 |
Price | 9.42 |
Earnings Yield | -17.20% |
PEGY Ratio | -0.3344 |